Search

Your search keyword '"Devito C."' showing total 50 results

Search Constraints

Start Over You searched for: Author "Devito C." Remove constraint Author: "Devito C." Language english Remove constraint Language: english
50 results on '"Devito C."'

Search Results

6. High zonal harmonics of rapidly rotating planets

8. Use of Veterans Affairs medical care by enrollees in Medicare HMOs.

9. Differential Immune Response Patterns Induced by Anionic and Cationic Lipid Adjuvants in Intranasal Anti-Influenza Immunization.

10. Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein.

11. Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy.

12. Long-Lasting Mucosal and Systemic Immunity against Influenza A Virus Is Significantly Prolonged and Protective by Nasal Whole Influenza Immunization with Mucosal Adjuvant N3 and DNA-Plasmid Expressing Flagellin in Aging In- and Outbred Mice.

13. Human IgM monoclonal antibodies block HIV-transmission to immune cells in cervico-vaginal tissues and across polarized epithelial cells in vitro.

14. Targeting cancer stem-like cells as an approach to defeating cellular heterogeneity in Ewing sarcoma.

15. DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant.

16. Antiretroviral therapy does not induce HIV type 1-specific neutralizing activity against autologous HIV type 1 isolates.

17. A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations.

18. Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity.

19. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41.

20. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.

21. Oppositional defiant disorder with onset in preschool years: longitudinal stability and pathways to other disorders.

22. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers.

23. Attachment, parenting, and marital dissatisfaction as predictors of disruptive behavior in preschoolers.

24. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells.

25. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate.

26. Medicare HMO disenrollment and selective use of medical care: osteoarthritis-related joint replacement.

27. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.

28. Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents.

29. Racial and income differences in use of the hospice benefit between the medicare managed care and medicare fee-for-service.

30. Do Medicare HMOs and Medicare FFS differ in their use of the Medicare hospice benefit?

31. Home environmental hazards and the risk of fall injury events among community-dwelling older persons. Study to Assess Falls Among the Elderly (SAFE) Group.

32. Medicare HMOs: who joins and who leaves?

33. Seroreactivity to HIV-1 V3 subtypes A to H peptides of Argentinian HIV-positive sera.

34. The Medicare-HMO revolving door--the healthy go in and the sick go out.

35. Chronic medical conditions and risk of fall injury events at home in older adults.

37. A standardized instrument to assess hazards for falls in the home of older persons.

39. Accuracy tests of tooth formation age estimations for human skeletal remains.

40. Alcohol as a risk factor for fall injury events among elderly persons living in the community.

41. A language based on the fundamental facts of science.

42. The incidence of fall injury events among the elderly in a defined population.

44. Linking LTC patients and community resources.

46. Impact of drug substitution legislation--implications for continuing education for Michigan pharmacists.

47. Framework and development of a comprehensive drug product coding system.

48. Fall injuries among the elderly. Community-based surveillance.

49. Medical self-care education for elders: a controlled trial to evaluate impact.

50. Correlation of Anagram Solving to Transition Probability and Word Frequency.

Catalog

Books, media, physical & digital resources